Webinar: Interpreting Human Next-Gen Sequencing Data with the knoSYS® Platform
Presenter: Ben Salisbury, PhD, SVP of Clinical Products at Knome
Date: August 14, 2014
Abstract
Every week a major new genomic initiative is announced that will revolutionize healthcare. Advances in sequencing technologies catalyzing these efforts are well documented. But how are organizations leveraging this technology to drive clinically actionable information? Why is bioinformatics still a bottleneck? What is the infrastructure needed to make sense of the data?
Join us on August 14th as Dr. Ben Salisbury, Senior Vice President of Clinical Products at Knome, presents the knoSYS® platform, a powerful genomic interpretation system that combines a high-performance computing environment with easy-to-use interpretation software. He will cover how informatics systems, public and private annotation databases, and novel in silico genomic panels can be combined to effectively use genetic information to facilitate diagnosis and guide treatment in a collaborative, interdisciplinary team environment.
Topics include:
- Overview of the pipeline for generating, aligning and calling, and interpreting sequence data.
- Public and private online database options for annotating and interpreting variants.
- Demonstration of in silico panels using the knoSYS platform.
- Typical workflows for investigating sequence data as well as the process of running predefined and on-the-fly panels to get meaningful results.
Dr. Salisbury’s career has been spent in the personalized medicine and genomics industries. He joined Knome in 2012 and currently holds the position of Senior Vice President of Clinical Products where he acts as a liaison between marketplace needs and development of the knoSYS® platform. Prior to joining Knome, he served in various scientific and management roles at Genaissance Pharmaceuticals, Clinical Data, and Transgenomic. His expertise spans several areas of genetic research and its clinical application, including molecular diagnostics, personalized medicine, population and statistical genetics, and software and algorithm development. Dr. Salisbury holds degrees in biology from Yale University and the University of Michigan.